Skip to content

Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage

Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02229513
Enrollment
200
Registered
2014-09-01
Start date
2013-07-31
Completion date
2014-08-31
Last updated
2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage, Uterine Atony

Keywords

postpartum hemorrhage, uterine atony, cesarean section, cesarean hysterectomy, acute blood loss anemia, uterotonics, obstetric hemorrhage, severe hemorrhage, blood transfusion, obstetric emergencies, obstetrics, massive hemorrhage, hemorrhage, uterine cooling

Brief summary

The objective of the study is to demonstrate whether cooling the uterine smooth muscle during cesarean section (following delivery of the fetus) will promote better uterine contraction and involution resulting in lower blood loss, use of fewer uterotonic medications, and fewer hysterectomies following cesarean section. The investigators suspect that it may.

Detailed description

Study Design: Patients will be randomly assigned to either the study group or the control group. Patients may receive regional (epidural or spinal/epidural) or general anesthesia.Initially, the investigators plan to enroll 200 subjects, 100 to the study group and 100 to the control group. Following delivery of the fetus, patients in the study group also will have Pitocin® administered to them according to the usual protocol.Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. The skin of the abdomen will be draped to prevent contact with the cold towels. Additional uterotonic medications may be given at the discretion of the attending obstetrician. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen. The surface temperature of the uterus will be measured using an infrared thermometer prior to replacing the uterus into the abdomen. Two surgical suction canisters will be available. Immediately after delivery of the fetus and prior to delivery of the placenta, the amniotic fluid and blood on the surgical field will be aspirated into the first canister. The second suction canister will be used to aspirate blood and fluid until the conclusion of the operation. At the conclusion of the surgery blood loss will be calculated by measuring the content of blood in the second canister minus the amount of irrigation fluid used, and by weighing the surgical sponges. Average blood loss during cesarean sections has previously been reported as 500 to 1000 cc. The duration of cooling the uterus will be recorded. Use and amount of uterotonic medications also will be recorded. During the surgery the patient's vital signs will be monitored in the usual fashion. Particular attention will be paid to a change in her temperature. Warmed blankets and forced air warming blankets will be used to maintain normothermia, if required. At the conclusion of the study the amount of blood loss between the control and study groups, and the amount of uterotonic drugs will be calculated and compared. The number of patients in each group who require additional surgeries, e.g. hysterectomy or D&C, will be monitored. Pre-op and post-op hemograms will be compared if obtained at the discretion of the attending obstetrician. Blood product administration will be recorded. Determination of an ideal temperature of cooling towels is not an objective of the study. We're asking a qualitative question, not a quantitative question at this time. Study Rationale: The uterus is a smooth muscle whose contraction is modulated most directly by intrinsic or extrinsic oxytocin. During pregnancy the spiral arteries within the uterus and beneath the placenta enlarge to provide adequate perfusion to the placenta. After separation of the placenta the uterine smooth muscle cells contract in a pincer-like action to pinch the spiral arteries closed. When uterine contraction is inadequate (approximately 4-6% of normal pregnancies) the spiral arteries continue to bleed. If not addressed the bleeding can be excessive, even leading to maternal death. Approximately 5-8 out of 1,000 cesarean sections require hysterectomy to control bleeding. Release of calcium ions from sarcoplasmic reticulum stores is the immediate initiator of contraction, and calcium's diffusion from the muscle filaments and re-uptake by the sarcoplasmic reticulum results in relaxation of contraction. In some smooth muscles cold enhances contraction; perhaps by slowing the re-uptake of calcium. When the usual pharmacologic agents fail to induce adequate contraction of the uterine smooth muscle, the investigators suspect that application of cold may.

Interventions

PROCEDUREUterine Cooling

Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus cephalad to the hysterotomy incision will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.

Sponsors

Baylor Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant adult women of any gravidity, and gestational duration who present for cesarean section at Baylor University Medical Center in Dallas and who have given informed consent to be in the study.

Exclusion criteria

* Women who refuse to be in the study, and women who are unable to consent due to emergent nature of the cesarean section will be excluded. Women who are unable to understand the nature of the study due to mental illness, mental retardation, medical condition, or other communication barrier will be excluded. * Inability to exteriorize the uterus during c-section.

Design outcomes

Primary

MeasureTime frameDescription
Blood LossDuring surgery and in the PACU (approximately 3 total hours)At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads.

Secondary

MeasureTime frame
Total Blood Loss Greater Than 1000 ccIntra-op, Post-Op
Requirement of Cesarean HysterectomyDuring surgery and in the PACU (approximately 3 total hours)
Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical InterventionsIntraoperatively
Change in Pre- vs Post-operative Hematocrit48 hours post operative period
Use of Uterotonic MedicationsDuring surgery and in the PACU (approximately 3 total hours)
Use of Extra OxytocinIntraoperatively
Use of MethergineIntraoperatively
Use of HemabateIntraoperatively
Use of CytotecIntraoperatively
Bakri Bulb PlacementIntraoperatively
Requirement of Blood ProductsDuring surgery and in the PACU (approximately 3 total hours)

Other

MeasureTime frame
Patient TemperaturePre-op, Intra-op, Post-Op
Total Time Uterus WrappedDuring hysterotomy repair
Uterine Temperature After Wrap RemovedImmediately following hysterotomy repair

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Normal cesarean technique.
100
Uterine Cooling
Immediately following delivery of the fetus the uterus will be externalized in the usual fashion and the body of the uterus will be wrapped in sterile surgical towels saturated in sterile, iced normal saline. These towels will come from a sterile cooling pot set to 30 degrees Fahrenheit. Iced saline-soaked towels will be kept in place for a minimum of 5 minutes and replaced at the discretion of the attending obstetrician until the hysterotomy is closed and the uterus is replaced into the patient's abdomen.
100
Total200

Baseline characteristics

CharacteristicControlUterine CoolingTotal
Age, Continuous30.1 years
STANDARD_DEVIATION 4.8
31.7 years
STANDARD_DEVIATION 5.1
30.9 years
STANDARD_DEVIATION 5
Fetal Presentation
Breech
14 participants14 participants28 participants
Fetal Presentation
Cephalic
84 participants83 participants167 participants
Fetal Presentation
Compound
0 participants1 participants1 participants
Fetal Presentation
Oblique
1 participants0 participants1 participants
Fetal Presentation
Transverse
1 participants2 participants3 participants
Fetal Weight (g)3504 grams
STANDARD_DEVIATION 852
3471 grams
STANDARD_DEVIATION 822
3488 grams
STANDARD_DEVIATION 835
Gestational Age (wks)38.5 weeks
STANDARD_DEVIATION 2.2
38.0 weeks
STANDARD_DEVIATION 4.2
38.3 weeks
STANDARD_DEVIATION 3.4
Gravidity2.5 pregnancies2.4 pregnancies2.5 pregnancies
Height (ft)5.4 feet
STANDARD_DEVIATION 0.2
5.4 feet
STANDARD_DEVIATION 0.3
5.4 feet
STANDARD_DEVIATION 0.3
Multiple Gestations
no
89 participants93 participants182 participants
Multiple Gestations
yes
11 participants7 participants18 participants
Parity1.0 births1.0 births1.0 births
Pre-op Epidural
no
91 participants83 participants174 participants
Pre-op Epidural
yes
9 participants17 participants26 participants
Previous Cesareans0.8 cesareans0.7 cesareans0.8 cesareans
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
4 Participants5 Participants9 Participants
Race (NIH/OMB)
Black or African American
14 Participants17 Participants31 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
82 Participants78 Participants160 Participants
Sex: Female, Male
Female
100 Participants100 Participants200 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Trial of Labor
no
93 participants84 participants177 participants
Trial of Labor
yes
7 participants16 participants23 participants
Weight (lbs)200 pounds
STANDARD_DEVIATION 49
187 pounds
STANDARD_DEVIATION 39
194 pounds
STANDARD_DEVIATION 45

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1000 / 100
serious
Total, serious adverse events
0 / 1000 / 100

Outcome results

Primary

Blood Loss

At the conclusion of the surgery, blood loss will be calculated by measuring the content of blood in the suction canister, and by weighing the surgical sponges. The amount of blood loss in the PACU will be measured by weighing pads.

Time frame: During surgery and in the PACU (approximately 3 total hours)

ArmMeasureGroupValue (MEAN)Dispersion
ControlBlood LossIntraoperative blood loss616 ccStandard Deviation 411
ControlBlood LossPACU blood loss141 ccStandard Deviation 199
ControlBlood LossTotal blood loss756 ccStandard Deviation 462
Uterine CoolingBlood LossIntraoperative blood loss418 ccStandard Deviation 317
Uterine CoolingBlood LossPACU blood loss106 ccStandard Deviation 170
Uterine CoolingBlood LossTotal blood loss536 ccStandard Deviation 429
Secondary

Bakri Bulb Placement

Time frame: Intraoperatively

ArmMeasureGroupValue (NUMBER)
ControlBakri Bulb Placementyes3 participants
ControlBakri Bulb Placementno97 participants
Uterine CoolingBakri Bulb Placementyes0 participants
Uterine CoolingBakri Bulb Placementno100 participants
Secondary

Change in Pre- vs Post-operative Hematocrit

Time frame: 48 hours post operative period

ArmMeasureValue (MEAN)Dispersion
ControlChange in Pre- vs Post-operative Hematocrit4.3 percentStandard Deviation 3.6
Uterine CoolingChange in Pre- vs Post-operative Hematocrit4.8 percentStandard Deviation 3.1
Secondary

Requirement of Blood Products

Time frame: During surgery and in the PACU (approximately 3 total hours)

ArmMeasureGroupValue (NUMBER)
ControlRequirement of Blood Productsyes2 participants
ControlRequirement of Blood Productsno98 participants
Uterine CoolingRequirement of Blood Productsyes3 participants
Uterine CoolingRequirement of Blood Productsno97 participants
Secondary

Requirement of Cesarean Hysterectomy

Time frame: During surgery and in the PACU (approximately 3 total hours)

ArmMeasureGroupValue (NUMBER)
ControlRequirement of Cesarean Hysterectomyyes0 participants
ControlRequirement of Cesarean Hysterectomyno100 participants
Uterine CoolingRequirement of Cesarean Hysterectomyyes0 participants
Uterine CoolingRequirement of Cesarean Hysterectomyno100 participants
Secondary

Total Blood Loss Greater Than 1000 cc

Time frame: Intra-op, Post-Op

ArmMeasureGroupValue (NUMBER)
ControlTotal Blood Loss Greater Than 1000 ccyes21 participants
ControlTotal Blood Loss Greater Than 1000 ccno79 participants
Uterine CoolingTotal Blood Loss Greater Than 1000 ccyes9 participants
Uterine CoolingTotal Blood Loss Greater Than 1000 ccno91 participants
Secondary

Use of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventions

Time frame: Intraoperatively

ArmMeasureGroupValue (NUMBER)
ControlUse of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventionsyes6 participants
ControlUse of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventionsno94 participants
Uterine CoolingUse of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventionsyes5 participants
Uterine CoolingUse of Additional Measures to Control Blood Loss, Including Pharmacological and Surgical Interventionsno95 participants
Secondary

Use of Cytotec

Time frame: Intraoperatively

ArmMeasureGroupValue (NUMBER)
ControlUse of Cytotecyes4 participants
ControlUse of Cytotecno96 participants
Uterine CoolingUse of Cytotecyes3 participants
Uterine CoolingUse of Cytotecno97 participants
Secondary

Use of Extra Oxytocin

Time frame: Intraoperatively

ArmMeasureGroupValue (NUMBER)
ControlUse of Extra Oxytocinyes1 participants
ControlUse of Extra Oxytocinno99 participants
Uterine CoolingUse of Extra Oxytocinyes1 participants
Uterine CoolingUse of Extra Oxytocinno99 participants
Secondary

Use of Hemabate

Time frame: Intraoperatively

ArmMeasureGroupValue (NUMBER)
ControlUse of Hemabateyes1 participants
ControlUse of Hemabateno99 participants
Uterine CoolingUse of Hemabateyes2 participants
Uterine CoolingUse of Hemabateno98 participants
Secondary

Use of Methergine

Time frame: Intraoperatively

ArmMeasureGroupValue (NUMBER)
ControlUse of Methergineyes2 participants
ControlUse of Methergineno98 participants
Uterine CoolingUse of Methergineyes2 participants
Uterine CoolingUse of Methergineno98 participants
Secondary

Use of Uterotonic Medications

Time frame: During surgery and in the PACU (approximately 3 total hours)

ArmMeasureGroupValue (NUMBER)
ControlUse of Uterotonic Medicationsyes5 participants
ControlUse of Uterotonic Medicationsno95 participants
Uterine CoolingUse of Uterotonic Medicationsyes4 participants
Uterine CoolingUse of Uterotonic Medicationsno96 participants
Other Pre-specified

Patient Temperature

Time frame: Pre-op, Intra-op, Post-Op

ArmMeasureGroupValue (MEAN)Dispersion
ControlPatient TemperaturePost-operative97.8 degrees FahrenheitStandard Deviation 0.4
ControlPatient TemperaturePre-operative98.3 degrees FahrenheitStandard Deviation 0.4
ControlPatient TemperatureIntra-operative97.7 degrees FahrenheitStandard Deviation 1
Uterine CoolingPatient TemperatureIntra-operative97.9 degrees FahrenheitStandard Deviation 0.7
Uterine CoolingPatient TemperaturePre-operative98.4 degrees FahrenheitStandard Deviation 0.7
Uterine CoolingPatient TemperaturePost-operative97.9 degrees FahrenheitStandard Deviation 1
Other Pre-specified

Total Time Uterus Wrapped

Time frame: During hysterotomy repair

ArmMeasureValue (MEAN)Dispersion
ControlTotal Time Uterus Wrapped9.3 minutesStandard Deviation 4.3
Uterine CoolingTotal Time Uterus Wrapped9.4 minutesStandard Deviation 4
Other Pre-specified

Uterine Temperature After Wrap Removed

Time frame: Immediately following hysterotomy repair

ArmMeasureValue (MEAN)Dispersion
ControlUterine Temperature After Wrap Removed88.3 degrees FahrenheitStandard Deviation 3
Uterine CoolingUterine Temperature After Wrap Removed75.5 degrees FahrenheitStandard Deviation 7.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026